학술논문
Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
Document Type
Correspondence
Author
Source
In Blood Advances 28 February 2023 7(4):644-648
Subject
Language
ISSN
2473-9529